1. OP17 Upadacitinib Improves Endoscopic Outcomes in Patients with Moderate to Severely Active Crohn's Disease Irrespective of Previous Failure to Respond to Biologics or Conventional Therapies. (30th January 2023) Authors: Feagan, B G; Horst, S; Dryden, G; Lindsay, J O; Ferrante, M; Dubenco, E; Lacerda, A P; Ford, S; Anyanwu, S I; Zhou, Q; Liu, J; Chen, M; Schreiber, S Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.154 Characterizing and comparing brain injury associated with traditional self-retracting brain retractors with novel tubular retractors. (June 2022) Authors: Naeem, A; Dryden, G; Hammond, R; Speechley, M; Wade, K; Boulton, M Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.211 Characterizing and comparing brain injury associated with traditional self-retracting brain retractors with novel tubular retractors. (November 2021) Authors: Naeem, A; Dryden, G; Hammond, R; Speechley, M; Wade, K; Boulton, M Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗